Finally, the MAPK/ERK signaling pathway is activated in more than 50% of human HCC cases (145) by a range of growth factor receptors in HCC including VEGF-R, EGF-R, FGF-R, PDGF-R and C-MET that interlink with angiogenic expression (146). Here, MET is linked to hepatocellular carcinoma.